FRANCISCO
CASAS MALDONADO
PROFESOR ASOCIADO CIENCIAS SALUD
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (25)
2023
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
International Journal of COPD, Vol. 18, pp. 1691-1700
2021
2020
2019
-
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia
International Journal of Tuberculosis and Lung Disease, Vol. 23, Núm. 10, pp. 1100-1106
2018
-
Alpha-1 antitrypsin deficiency: Outstanding questions and future directions
Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1
-
Geographical Distribution of COPD Prevalence in the Americas
COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 15, Núm. 4, pp. 317-325
-
Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique
International Journal of COPD, Vol. 13, pp. 57-67
-
Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the spanish registry (REDAAT)
International Journal of COPD, Vol. 13, pp. 1001-1007
2017
-
Alpha-1 antitrypsin Pi*SZ genotype: Estimated prevalence and number of SZ subjects worldwide
International Journal of COPD, Vol. 12, pp. 1683-1694
-
Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: An update
International Journal of COPD, Vol. 12, pp. 561-569
-
Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry
PLoS ONE, Vol. 12, Núm. 5
-
Etiología de las bronquiectasias en una cohorte de 2.047 pacientes. Análisis del registro histórico español
Archivos de Bronconeumologia, Vol. 53, Núm. 7, pp. 366-374
-
Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis
Archivos de Bronconeumologia, Vol. 53, Núm. 1, pp. 13-18
2016
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8
-
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment
Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268
-
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients
Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152
2015
-
Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update
Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 185-192
2011
-
Factores asociados a la evolución de la función pulmonar en pacientes con déficit de alfa-1-antitripsina del registro español
Archivos de Bronconeumologia, Vol. 47, Núm. 10, pp. 495-503